The IFPMA Code Compliance Network (CCN) Global Comparison of research-based pharmaceutical Codes of Practices Chart is the collected feedback of IFPMA member associations and provides a general overview of national and regional associations’ Codes and their related provisions. This chart reflects the 2012 revision of the IFPMA Code which came into global effect on 1 September 2012.
This Comparison Chart provides a snapshot of the global research-based pharmaceutical industry’s self-regulation mechanisms and the commitment of IFPMA members to ethical promotion of medicines and ethical interactions with healthcare professionals, patient organizations and medical institutions, for the safety and benefit of patients worldwide.
It should be noted that the intention of this chart is not to provide a comprehensive analysis of regional and national association Codes. In this manner, the comparison chart does not include a precise account of national Codes’ requirements, depth of coverage or additional provisions. For detailed information regarding provisions in a specific country, please refer to the respective national Codes.
To access IFPMA national member association Codes please click here.
To view the IFPMA CCN Global Comparison Chart, please click here.